Intravenous and intramyocardial administration of bone marrow mesenchymal stromal cells cannot improve heart function in a rat model of chronic myocardial infarction
10.3969/j.issn.2095-4344.2015.10.010
- VernacularTitle:静脉及心肌注射骨髓间充质基质细胞未能改善慢性心肌梗死大鼠的心脏功能
- Author:
Wei WANG
;
Debin LIU
;
Ying FENG
;
Hao ZHANG
;
Shixiong WANG
;
Bingren GAO
;
Jing ZHANG
;
Weifan WANG
- Publication Type:Journal Article
- Keywords:
Bone Marrow;
Mesenchymal Stem Cel Transplantation;
Myocardial Infarction;
Heart Function Tests
- From:
Chinese Journal of Tissue Engineering Research
2015;(10):1528-1532
- CountryChina
- Language:Chinese
-
Abstract:
BACKGROUND:It has been demonstrated to be effective for the improvement of heart function after acute myocardial infarction with intravenous or intramyocardial administration of bone marrow mesenchymal stromal cels. However, little is known regarding the effect of the combination of intravenous and intramyocardial administration of mesenchymal stromal cels on the heart function of a chronic myocardial infarction model. OBJECTIVE:To study the effect of intravenous and intramyocardial administration of bone marrow mesenchymal stromal cels on the heart function of a rat chronic myocardial infarction model and the relevant mechanism. METHODS:Bone marrow mesenchymal stromal cels isolated from Lewis rats were expandedex vivo. BrdU-labeled bone marrow mesenchymal stromal cels (3×106) were administeredvia the femoral vein and the myocardial surface respectively into rat models of chronic myocardial infarction in cel transplantation group. The equal volume of PBS was injected into the same place in control group. Four weeks after injection, echocardiography was performed to evaluate the heart function, and then the heart tissues were harvested for immunohistochemistry examination. The total blood vessel density in the scar area was evaluated. RESULTS AND CONCLUSION:At 4 weeks after cel implantation, the left ventricular function was not improved in the two groups. The immunohistochemistry staining showed that (1) the mesenchymal stromal cels in the myocardium did not differentiate to myocardial cels; (2) there was no significant difference in the total blood vessel density in the scar area between the cel transplantation and control groups. Taken together, the combined intravenous and intramyocardial administration of bone marrow mesenchymal stromal cels cannot improve heart function in a rat chronic myocardial infarction model.
